Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah C Gilbert

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
Clinical and Experimental Immunology|February 2, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trialsMerryn Voysey, Amy Flaxman, Jeremy Aboagye, et al.
Nature|July 31, 2020
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
Nature|January 20, 2021
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
The Lancet. HIV|August 20, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trialShabir A Madhi, Anthonet L Koen, Alane Izu, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
NPJ Vaccines|August 15, 2020
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19Simon P Graham, Rebecca K McLean, Alexandra J Spencer, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
Annals of the New York Academy of Sciences|October 2, 2022
Lessons from the pandemic: Responding to emerging zoonotic viral diseases-a Keystone Symposia reportJennifer Cable, Anthony Fauci, William E Dowling, et al.
Lancet (London, England)|September 4, 2021
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, et al.
Clinical and Experimental Immunology|February 2, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trialsMerryn Voysey, Amy Flaxman, Jeremy Aboagye, et al.
Nature|July 31, 2020
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
Nature|January 20, 2021
Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaquesNeeltje van Doremalen, Teresa Lambe, Alexandra Spencer, et al.
The Lancet. HIV|August 20, 2021
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trialShabir A Madhi, Anthonet L Koen, Alane Izu, et al.
NPJ Vaccines|July 23, 2025
Nipah virus vaccines evaluated in pigs as a 'One Health' approach to protect public healthRebecca K McLean, Miriam Pedrera, Nazia Thakur, et al.
NPJ Vaccines|May 3, 2026
Searching for immune correlates in Lassa vaccine development - workshop reportTrevor Brasel, Polina Brangel, Ifedayo Adetifa, et al.
NPJ Vaccines|August 15, 2020
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19Simon P Graham, Rebecca K McLean, Alexandra J Spencer, et al.
Pageof 22